Important Announcement

2 February, 2021 at 8:21 AM

Visit Back2BU for the latest updates and information on BU's response to COVID-19. Students can find additional information in the Undergraduate Student Guide and Graduate & Professional Student Guide.

Skip to Main Content
School of Public Health

​
  • Admissions
  • Research
  • Education
  • Practice
​
Search
  • Newsroom
    • Latest News
    • SPH This Week
    • SPH in the Media
    • SPH This Year
    • Sections
  • Research
    • Research Contact Information
    • idea hub
    • Biostatistics and Epidemiology Data Analytics Center (BEDAC)
  • Education
    • Degrees & Programs
    • Learn From Anywhere Format
    • Continuing and Professional Education
    • Public Health Writing
  • Admissions
    • Applying to BUSPH
    • Admissions Team
    • Why BUSPH
    • Financing Your Public Health Education
    • SPH Class Profile
    • Events and Campus Visits
    • Request Information
    • Frequently Asked Questions
    • Part-Time Options
  • Events
    • Public Health Conversations
    • Community Events
    • Calendar
  • Practice
    • Activist Lab
  • Careers & Practicum
    • About Us
    • For Students
    • For Alumni
    • For Employers
    • For Faculty and Staff
    • Graduate Employment and Practicum Data
    • Career Newsletter
    • Career Services Calendar
  • Public Health Post
  • About
    • Senior Leadership
    • COVID-19 Response
    • SPH at a Glance
    • Strategy Map
    • Diversity, Equity, Inclusion, and Justice
    • Accreditation
    • Visit SPH
    • Partnerships
    • Academic Departments
    • Offices & Centers
    • Committees
    • SPH45
    • Directory
  • Support SPH
    • #SPH45
    • The Activist Lab
    • Big Ideas
    • Faculty Research and Development
    • Future of Public Health Fund
    • Global Network
    • idea hub
    • Population Health Exchange
    • Public Health Conversations
    • Public Health Post
    • Student Scholarship
    • SPH45 Anniversary Celebration
    • How to Give
    • Contact Us
  • Students
  • Faculty & Staff
  • Alumni
  • Directory
Read More News
In Zambia, 80 Percent of Infant Deaths Come After Delays in Care
infant mortality

In Zambia, Most Infant Deaths Come After Delays in Care

Who Feels the Heat?
climate change

Who Feels the Heat?

More Resources Needed for Drug-Resistant Tuberculosis.

April 13, 2015
Twitter Facebook

chest-x-rayInvestments in early diagnosis and treatment of multidrug-resistant tuberculosis are crucial for better patient outcomes, two School of Public Health researchers write in The Lancet Global Health.

In an article accompanying a new study of multidrug-resistant tuberculosis (MDRTB) care in China, authors Karen Jacobson, an assistant professor of medicine at the School of Medicine and assistant professor of epidemiology at SPH, and Lora Sabin, associate professor of global health at SPH, say there is “mounting evidence” that investments in coordinating MDRTB care will produce better outcomes.

Specifically, they say the new study by the Chinese Center for Disease Control and Prevention, which reports on an intervention to provide universal access to MDRTB care, shows that “a faster time to diagnosis has both clinical and cost benefits: elimination of hospital stay preceding diagnosis, which reduces potential nosocomial transmission of MDRTB along with hospital expenses, and faster initiation of MDRTB treatment.”

China has a quarter of all patients with multidrug-resistant tuberculosis worldwide, but less than 5 percent are in quality treatment programs. The Chinese study assessed the effectiveness of a program providing universal access to diagnosis, treatment, and follow-up for MDRTB in four Chinese cities.

The program, which included free testing for MDRTB, could cost $500 million annually, Sabin and Jacobson write. While that spending is “substantial,” it represents only about 0.2 percent of annual public health spending in China.

“Moreover,” they write, “extrapolating the mortality effect shown in (the) study, MDRTB-related deaths could be reduced by roughly 80 percent, with up to 20,000 deaths averted in the first year alone.”

The pair concludes that while comprehensive, high-quality treatment models are challenging logistically and financially, the Chinese model has potential “for achieving advances in tuberculosis treatment relatively swiftly.

“As improved diagnostics and drugs for MDRTB become available, the relevance of such a complete, integrated approach to diagnosis, treatment, and cost to scale-up MDRTB care will only continue to grow.”

Submitted by: Lisa Chedekel

Explore Related Topics:

  • epidemiology
  • Global Health
  • MDRTB
  • tuberculosis
  • Share this story

Share

More Resources Needed for Drug-Resistant Tuberculosis

  • Twitter
  • Facebook
  • Reddit
  • LinkedIn
  • Email
  • Print

More about SPH

Sign up for our newsletter

Get the latest from Boston University School of Public Health

Subscribe

Also See

  • About
  • Newsroom
  • Contact
  • Support SPH

Resources

  • Students
  • Faculty & Staff
  • Alumni
  • Directory
  • Boston University School of Public Health
  • 715 Albany Street, Boston, MA 02118
  • © 2021 Trustees of Boston University
  • DMCA
  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • Instagram
© Boston University. All rights reserved. www.bu.edu
Boston University Masterplate
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.